Martacet 37,5 mg/ 325 mg FC tablets
PDF Leaflet Revision Date: 14 June 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Management of moderate to moderately severe pain in adults.
Dosage (summary)
1-2 tablets every 4-6 hours, max 8 tablets/day.
Onset of Action / Duration
Onset: 2-3 hours, Duration: 6-8 hours
Special Populations
- Renal impairment
Pregnancy & Breastfeeding
Not recommended in pregnancy; safety in lactation not established.
Key Drug Interactions
- MAO inhibitors
- Alcohol
- CNS depressants
Contraindications
- Hypersensitivity to tramadol or paracetamol
- Severe liver impairment
- Respiratory depression
- Epilepsy not controlled by treatment
Common side effects
- Dizziness
- Nausea
- Constipation
- Somnolence
- Skin rash
Counselling Points
- Do not exceed recommended dose
- Avoid alcohol
- Monitor for signs of serious skin reactions
Serious warnings
- Risk of seizures
- Potential for dependence
- Risk of overdose
Important Disclaimer
The Martacet 37,5 mg/ 325 mg FC tablets professional information leaflet below is the property of Novagen Pharma and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
